4//SEC Filing
Wang Xiaolin 4
Accession 0001567619-22-013253
CIK 0001628171other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 5:03 PM ET
Size
5.1 KB
Accession
0001567619-22-013253
Insider Transaction Report
Form 4
Wang Xiaolin
See Remarks
Transactions
- Sale
Common Stock
2022-06-17$17.75/sh−665$11,803→ 31,970 total
Footnotes (3)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]Includes 937 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022.
- [F3]Includes 26,450 RSUs.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001849181
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 5:03 PM ET
- Size
- 5.1 KB